Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity
NCT06214468 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 26
Last updated 2026-04-06
Summary
Over-the-counter drugs like acetaminophen (e.g., Tylenol®) can be detrimental. In space, astronauts who have pain and constant discomfort use acetaminophen extensively. Investigators are studying the effects of acetaminophen under space-like conditions since acetaminophen might affect astronauts' health. Investigators also wish to see whether a dietary supplement can reduce some negative effects of acetaminophen.
It is believed that acetaminophen promotes the productions of chemicals in the body that could be toxic.
In this study, measurements of these chemicals in urine after ingestion of 1 tablet of acetaminophen and compare these measurements to when acetaminophen is taken at the same time as a dietary supplement. This study will also explore whether these products are more abundant when blood is placed under conditions that mimic space. Therefore, this study will collect blood from a few volunteers who took acetaminophen, and acetaminophen with the dietary supplement.
Conditions
- Drug Toxicity
Interventions
- COMBINATION_PRODUCT
-
Acetaminophen and Nicotinamide Riboside
Collection of urine at different time intervals following ingestion of Tylenol plus Nicotinamide Riboside
- DRUG
-
Collection of urine at different time intervals following ingestion of Tylenol only
Sponsors & Collaborators
-
National Aeronautics and Space Administration (NASA)
collaborator FED -
University of Nevada, Las Vegas
collaborator OTHER -
University of Alabama at Birmingham
collaborator OTHER -
Rutgers University
collaborator OTHER -
University of South Alabama
lead OTHER
Principal Investigators
-
marie migaud, PHD · University of South Alabama
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-01-15
- Primary Completion
- 2025-04-01
- Completion
- 2025-06-01
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Use of NAC in Alleviation of Hangover Symptoms
NCT02541422 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Chemical Interactions in Toxicity
NCT00253773 ·Status: COMPLETED ·Phase: NA
-
The Effect of N- Acetylcysteine on Inflammatory and Oxidative Stress Biomarkers
NCT02420418 ·Status: UNKNOWN ·Phase: NA
-
Screening for Metabolic Problems in Mothers of Children With Autism and Typically Developing Children
NCT02674022 ·Status: COMPLETED ·Phase: NA
-
Oral Glutathione Supplementation on the Levels of Blood Glutathione
NCT01044277 ·Status: COMPLETED ·Phase: NA
-
Dietary Effects of Sulfur Amino Acids
NCT00228618 ·Status: COMPLETED
-
Use of NAC in Prevention of Hangover Symptoms; Independent Alcohol Consumption Protocol
NCT03104959 ·Status: TERMINATED ·Phase: NA
-
The Effects of N-acetylcysteine on Performance and Redox Homeostasis
NCT03121222 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems
NCT00889538 ·Status: COMPLETED ·Phase: NA
-
Acute Acetaminophen Ingestion: Does Repeated Acetaminophen Blood Test Have an Interest?
NCT01692639 ·Status: TERMINATED
-
Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
NCT01111734 ·Status: COMPLETED ·Phase: PHASE1
-
Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19
NCT04703036 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Metabolic Analysis in Human Sulfur Amino Acid Deficiency
NCT00253760 ·Status: COMPLETED ·Phase: NA
-
Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response
NCT04255368 ·Status: COMPLETED ·Phase: NA
-
Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women
NCT04125940 ·Status: COMPLETED ·Phase: NA
-
Prevention of Acute Radiation Enteritis With Glutamine
NCT00828399 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
NCT04542161 ·Status: RECRUITING ·Phase: PHASE2
-
The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19
NCT05371288 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Effects of Orotic Acid Derivatives With or Without Glutathione on Allergic Rhinitis
NCT00227058 ·Status: COMPLETED ·Phase: NA
-
DINAMITE Study Nutritional State and Effect Diet in Mitochondrial Disease
NCT02286856 ·Status: COMPLETED ·Phase: NA
-
Paracetamol and Glutathion
NCT01116596 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Liposomal Glutathione Supplementation in Healthy Subjects
NCT02278822 ·Status: COMPLETED ·Phase: NA
-
Effects of Glutathione (an Antioxidant) and N-Acetylcysteine on Inflammation
NCT01550432 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Adding Intravenous N-acetyl Cysteine in Colon Surgeries
NCT03589495 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of N-acetylcysteine on Brain Glutamate
NCT02483130 ·Status: COMPLETED